Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LAS - Insulin Glulisine for Lipoatrophy in Type 1 Diabetes
NCT02914886Phase 4Completed
- Sponsor
- Kinderkrankenhaus Auf der Bult
- Start
- Sep 2016
- Primary completion
- Apr 2019
01
Overview
Phase 4, randomised, open-label trial of human insulin in lipoatrophy (2 arms), sponsored by Kinderkrankenhaus Auf der Bult. Primary endpoint: Relative thickness as assessed by MRI at 6 months. Started Sep 2016; status: completed.
02
Drugs
human insulin
03
Conditions
lipoatrophy
Beyond the preview
Go deeper on NCT02914886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02914886.